{
  "responseHeader":{
    "status":0,
    "QTime":0,
    "params":{
      "q":"iati_identifier:GB-COH-03877777-F326101",
      "fl":"*",
      "format":"json"
    }
  },
  "response":{
    "numFound":1,
    "start":0,
    "numFoundExact":true,
    "docs":[{
      "last-updated-datetime":"2025-03-05T04:19:54Z",
      "last_updated_datetime":"Wed Mar 05 04:19:54 UTC 2025",
      "last_updated_datetime_f":"2025-03-05T04:19:54Z",
      "lang":"en",
      "default_lang":"en",
      "default-currency":"USD",
      "default_currency":"USD",
      "humanitarian":false,
      "hierarchy":1,
      "iati-identifier":"GB-COH-03877777-F326101",
      "iati_identifier":"GB-COH-03877777-F326101",
      "reporting-org.type":"15",
      "reporting_org_type_code":"15",
      "reporting-org.ref":"GB-COH-03877777",
      "reporting_org_ref":"GB-COH-03877777",
      "reporting-org.secondary-reporter":false,
      "reporting_org_secondary_reporter":"0",
      "reporting-org.narrative":[" British International Investment plc"],
      "reporting_org_narrative":[" British International Investment plc"],
      "reporting-org.narrative.lang":["en"],
      "title.narrative":["Dr Agarwal's Health Care Limited"],
      "title_narrative":["Dr Agarwal's Health Care Limited"],
      "title_narrative_text":["Dr Agarwal's Health Care Limited"],
      "title.narrative.lang":[" "],
      "title_narrative_lang":[" "],
      "description.type":["1"],
      "description_type":["1"],
      "description.narrative":["Dr Agarwal?s is a single-specialty healthcare business that provides world-class ophthalmology, optometry and associated laboratory/ pharmacy services to c. 900,000 patients per year. Dr Agarwal?s is the largest ophthalmology chain in India and operates in 10 countries across Africa. CDC has provided an INR 2,150 million (c. $31 million) loan to Dr Agarwal's Healthcare Limited that will be used to fund the company's continued expansion in India and in Africa."],
      "description_narrative":["Dr Agarwal?s is a single-specialty healthcare business that provides world-class ophthalmology, optometry and associated laboratory/ pharmacy services to c. 900,000 patients per year. Dr Agarwal?s is the largest ophthalmology chain in India and operates in 10 countries across Africa. CDC has provided an INR 2,150 million (c. $31 million) loan to Dr Agarwal's Healthcare Limited that will be used to fund the company's continued expansion in India and in Africa."],
      "description_narrative_text":["Dr Agarwal?s is a single-specialty healthcare business that provides world-class ophthalmology, optometry and associated laboratory/ pharmacy services to c. 900,000 patients per year. Dr Agarwal?s is the largest ophthalmology chain in India and operates in 10 countries across Africa. CDC has provided an INR 2,150 million (c. $31 million) loan to Dr Agarwal's Healthcare Limited that will be used to fund the company's continued expansion in India and in Africa."],
      "description.narrative.lang":[" "],
      "description_narrative_lang":[" "],
      "participating-org.ref":["GB-COH-03877777"],
      "participating_org_ref":["GB-COH-03877777"],
      "participating-org.type":["15"],
      "participating_org_type":["15"],
      "participating-org.role":["1"],
      "participating_org_role":["1"],
      "participating-org.narrative":["CDC Group Plc"],
      "participating_org_narrative":["CDC Group Plc"],
      "participating_org_narrative_text":["CDC Group Plc"],
      "participating-org.narrative.lang":[" "],
      "participating_org_narrative_lang":[" "],
      "activity-status.code":"2",
      "activity_status_code":"2",
      "activity-date.type":["2","1"],
      "activity_date_type":["2","1"],
      "activity-date.iso-date":["2019-11-05T00:00:00Z","2019-11-05T00:00:00Z"],
      "activity_date_iso_date":["2019-11-05T00:00:00Z","2019-11-05T00:00:00Z"],
      "contact-info.type":["4"],
      "contact_info_type":["4"],
      "contact-info.organisation.narrative":["Brisith International Investment plc"],
      "contact_info_organisation_narrative":["Brisith International Investment plc"],
      "contact_info_organisation_narrative_text":["Brisith International Investment plc"],
      "contact-info.organisation.narrative.lang":[" "],
      "contact_info_organisation_narrative_lang":[" "],
      "contact-info.department.narrative":["Communications Department"],
      "contact_info_department_narrative":["Communications Department"],
      "contact_info_department_narrative_text":["Communications Department"],
      "contact-info.department.narrative.lang":[" "],
      "contact_info_department_narrative_lang":[" "],
      "contact-info.telephone":["?+44 (0)20 7963 4700"],
      "contact_info_telephone":["?+44 (0)20 7963 4700"],
      "contact-info.email":["enquiries@bii.co.uk"],
      "contact_info_email":["enquiries@bii.co.uk"],
      "contact-info.website":["https://www.bii.co.uk"],
      "contact_info_website":["https://www.bii.co.uk"],
      "contact-info.mailing-address.narrative":["CDC Group plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"],
      "contact_info_mailing_address_narrative":["CDC Group plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"],
      "contact_info_mailing_address_narrative_text":["CDC Group plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"],
      "contact-info.mailing-address.narrative.lang":[" "],
      "contact_info_mailing_address_narrative_lang":[" "],
      "recipient-region.code":["679"],
      "recipient_region_code":["679"],
      "recipient-region.percentage":[100.0],
      "recipient_region_percentage":[100.0],
      "recipient-region.vocabulary":["1"],
      "recipient_region_vocabulary":["1"],
      "sector.code":["12220"],
      "sector_code":["12220"],
      "sector.vocabulary":["1"],
      "sector_vocabulary":["1"],
      "collaboration-type.code":"6",
      "collaboration_type_code":"6",
      "default-flow-type.code":"10",
      "default_flow_type_code":"10",
      "default-aid-type.code":["C01"],
      "default_aid_type":["C01"],
      "default_aid_type_category_code":["C01"],
      "default_aid_type_code":["C01"],
      "default-aid-type.vocabulary":["1"],
      "default_aid_type_vocabulary":["1"],
      "default-tied-status.code":"5",
      "default_tied_status_code":"5",
      "transaction.transaction-type.code":["2"],
      "transaction_type":["2"],
      "transaction.transaction-date.iso-date":["2019-11-05T00:00:00Z"],
      "transaction_date_iso_date":["2019-11-05T00:00:00Z"],
      "transaction.value":[2.339846741E7],
      "transaction_value":[2.339846741E7],
      "transaction.description.narrative":["$30m commitment by CDC to Dr Agarwal's Health Care Limited"],
      "transaction_description_narrative":["$30m commitment by CDC to Dr Agarwal's Health Care Limited"],
      "transaction.description.narrative.lang":[" "],
      "transaction_description_lang":[" "],
      "transaction.provider-org.ref":["GB-COH-03877777"],
      "transaction_provider_org_ref":["GB-COH-03877777"],
      "transaction.provider-org.provider-activity-id":["GB-COH-03877777"],
      "transaction_provider_org_provider_activity_id":["GB-COH-03877777"],
      "transaction.provider-org.type":["70"],
      "transaction_provider_org_type":["70"],
      "transaction.provider-org.narrative":["CDC Group Plc"],
      "transaction_provider_org_narrative":["CDC Group Plc"],
      "transaction_provider_org_narrative_text":["CDC Group Plc"],
      "transaction.provider-org.narrative.lang":[" "],
      "transaction_provider_org_narrative_lang":[" "],
      "transaction.receiver-org.ref":["CDC Group Plc"],
      "transaction_receiver_org_ref":["CDC Group Plc"],
      "transaction.receiver-org.narrative":["Dr Agarwal's Health Care Limited"],
      "transaction_receiver_org_narrative":["Dr Agarwal's Health Care Limited"],
      "transaction_receiver_org_narrative_text":["Dr Agarwal's Health Care Limited"],
      "transaction.receiver-org.narrative.lang":[" "],
      "transaction_receiver_org_narrative_lang":[" "],
      "transaction.value.value-date":["2019-11-05T00:00:00Z"],
      "transaction_value_date":["2019-11-05T00:00:00Z"],
      "reporting-org.type.name":"Other Public Sector",
      "reporting_org_type_name":"Other Public Sector",
      "recipient-region.name":["South Asia, regional"],
      "recipient_region_name":["South Asia, regional"],
      "default-aid-type.name":["Project-type interventions"],
      "default_aid_type_category_name":["Project-type interventions"],
      "title.narrative.first":"Dr Agarwal's Health Care Limited",
      "title_narrative_first":"Dr Agarwal's Health Care Limited",
      "activity-date.start-actual":"2019-11-05T00:00:00Z",
      "activity_date_start_actual":"Tue Nov 05 00:00:00 UTC 2019",
      "activity_date_start_actual_f":"2019-11-05T00:00:00Z",
      "activity-date.common.start":"2019-11-05T00:00:00Z",
      "activity_date_start_common":"Tue Nov 05 00:00:00 UTC 2019",
      "activity_date_start_common_f":"2019-11-05T00:00:00Z",
      "activity-date.start-planned":"2019-11-05T00:00:00Z",
      "activity_date_start_planned":"Tue Nov 05 00:00:00 UTC 2019",
      "activity_date_start_planned_f":"2019-11-05T00:00:00Z",
      "activity-status.text":"Implementation",
      "activity_status_text":"Implementation",
      "transaction.value-usd.sum":2.339846741E7,
      "transaction_value_usd_sum":2.339846741E7,
      "transaction.value-usd.conversion-rate":[1.0],
      "transaction_usd_conversion_rate":[1.0],
      "transaction.value-usd.conversion-currency":["USD"],
      "transaction.value-gbp.sum":1.816298845320818E7,
      "transaction_value_gbp_sum":1.816298845320818E7,
      "transaction.value-gbp.conversion-rate":[1.2882498642929583],
      "transaction_gbp_conversion_rate":[1.2882498642929583],
      "transaction.value-gbp.conversion-currency":["USD"],
      "dataset.id":"7e4b5f6f-a12c-4a85-b555-e63f75af07b5",
      "dataset_iati_id":"7e4b5f6f-a12c-4a85-b555-e63f75af07b5",
      "dataset.name":"bii-activities",
      "dataset_name":"bii-activities",
      "dataset.extras.iati_version":"2.03",
      "dataset.resources.hash":"45892ebb68e2a1f3ed94b9d52c4bb262558a46e3",
      "dataset.resources.url":"https://aidstream.s3.us-west-2.amazonaws.com/xml/bii-activities.xml",
      "activity-date.quarter":[4,4],
      "transaction.transaction-date.quarter":[4],
      "transaction.value-usd":[2.339846741E7],
      "transaction_value_usd":[2.339846741E7],
      "transaction.value-usd-type":[2],
      "transaction.value-gbp":[1.816298845320818E7],
      "transaction_value_gbp":[1.816298845320818E7],
      "transaction.value-gbp-type":[2],
      "activity-aggregation.outgoing-commitment.value":2.339846741E7,
      "activity_aggregation_commitment_value":2.339846741E7,
      "activity-aggregation.outgoing-commitment.value-usd":2.339846741E7,
      "activity_aggregation_commitment_value_usd":2.339846741E7,
      "activity-aggregation.outgoing-commitment.value-gbp":1.816298845320818E7,
      "activity_aggregation_commitment_value_gbp":1.816298845320818E7,
      "json.reporting-org":"{\"type\": 15, \"ref\": \"GB-COH-03877777\", \"secondary-reporter\": 0, \"narrative\": \" British International Investment plc\", \"narrative.lang\": \"en\"}",
      "json.title":"{\"narrative\": \"Dr Agarwal's Health Care Limited\", \"narrative.lang\": \" \"}",
      "json.description":["{\"type\": 1, \"narrative\": \"Dr Agarwal?s is a single-specialty healthcare business that provides world-class ophthalmology, optometry and associated laboratory/ pharmacy services to c. 900,000 patients per year. Dr Agarwal?s is the largest ophthalmology chain in India and operates in 10 countries across Africa. CDC has provided an INR 2,150 million (c. $31 million) loan to Dr Agarwal's Healthcare Limited that will be used to fund the company's continued expansion in India and in Africa.\", \"narrative.lang\": \" \"}"],
      "json.participating-org":["{\"ref\": \"GB-COH-03877777\", \"type\": 15, \"role\": 1, \"narrative\": \"CDC Group Plc\", \"narrative.lang\": \" \"}"],
      "json.activity-date":["{\"type\": 2, \"iso-date\": \"2019-11-05\"}","{\"type\": 1, \"iso-date\": \"2019-11-05\"}"],
      "json.contact-info":["{\"type\": 4, \"organisation\": {\"narrative\": \"Brisith International Investment plc\", \"narrative.lang\": \" \"}, \"department\": {\"narrative\": \"Communications Department\", \"narrative.lang\": \" \"}, \"telephone\": \"?+44 (0)20 7963 4700\", \"email\": \"enquiries@bii.co.uk\", \"website\": \"https://www.bii.co.uk\", \"mailing-address\": {\"narrative\": \"CDC Group plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom\", \"narrative.lang\": \" \"}}"],
      "json.recipient-region":["{\"code\": 679, \"percentage\": 100, \"vocabulary\": 1}"],
      "json.sector":["{\"code\": 12220, \"vocabulary\": 1}"],
      "json.default-aid-type":["{\"code\": \"C01\", \"vocabulary\": 1}"],
      "json.transaction":["{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2019-11-05\"}, \"value\": 23398467.41, \"description\": {\"narrative\": \"$30m commitment by CDC to Dr Agarwal's Health Care Limited\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"CDC Group Plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"ref\": \"CDC Group Plc\", \"narrative\": \"Dr Agarwal's Health Care Limited\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2019-11-05\"}"],
      "id":"5568bee2-8df7-4579-a234-02bb1bf94ea4",
      "_version_":1862855425754398720
    }]
  }
}